Identification of glycosyltransferase-related genes signature and integrative analyses in patients with ovarian cancer

被引:0
作者
Zhang, Yanqiu [1 ,2 ]
Zhou, Tong [1 ,3 ]
Tang, Qingqin [1 ]
Feng, Bin [1 ]
Liang, Yuting [1 ,4 ]
机构
[1] Soochow Univ, Ctr Clin Lab, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China
[2] Anhui Med Univ, Anhui Collaborat Innovat Ctr Antiinflammatory & Im, Key Lab Antiinflammatory & Immune Med, Minist Educ,Inst Clin Pharmacol, Hefei, Anhui, Peoples R China
[3] Soochow Univ, Med Coll, Suzhou, Jiangsu, Peoples R China
[4] Soochow Univ, Affiliated Hosp 1, Ctr Clin Lab, Suzhou 215006, Jiangsu, Peoples R China
关键词
Glycosyltransferase; ovarian cancer; tumor microenvironment; immune cell infiltration; VANGL1; CELLS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Glycosyltransferases (GT) play a crucial role in glycosylation reactions, and aberrant expression of glycosyltransferase-related genes (GTs) leads to abnormal glycosylation, which is associated with tumor progression. However, the prognostic value of aberrant expression of GTs in ovarian cancer (OC) and the correlation between GTs and tumor microenvironment (TME) remain unknown. Methods: TCGA and GSE53963 databases were used to obtain data on OC patient samples. The association of GTs with OC was analyzed. Molecular subtypes were identified by consensus unsupervised clustering, followed by immune infiltration and functional enrichment analyses. Survival analysis was performed using Kaplan-Meier curves and log -rank tests. Least Absolute Shrinkage and Selection Operator (LASSO) and multifactorial cox regression were used to screen for signature genes associated with OC and used to establish prognostic models. Result: OC patients were categorized into 5 GTs clusters using consensus unsupervised cluster analysis. Clusters D and E showed significant differences between survival, signaling pathways and immune infiltration. Then, a risk model was developed based on the 12 signature genes, which provides a more accurate evaluation of the prognosis of OC patients. We categorized patients into high -risk and low-risk groups based on the risk score and found that the survival of patients in the high -risk group was significantly lower than that in the low-risk group. Moreover, the risk score was significantly correlated with tumor microenvironment, immune infiltration, and chemotherapy sensitivity. Conclusion: Overall, we performed a comprehensive analysis of GTs in OC patients and developed a risk model for OC. Our findings will provide a new insight to OC prognosis and treatment.
引用
收藏
页数:15
相关论文
共 37 条
  • [1] Tumor-associated macrophage-targeted therapeutics in ovarian cancer
    An, Yuanyuan
    Yang, Qing
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (01) : 21 - 30
  • [2] Tumor Microenvironment
    Arneth, Borros
    [J]. MEDICINA-LITHUANIA, 2020, 56 (01):
  • [3] MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4
    Dong, Yilong
    Liu, Yang
    Jiang, Aimei
    Li, Ruiqian
    Yin, Min
    Wang, Yanmei
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 439 (1-2) : 95 - 104
  • [4] Real-world evidence in the treatment of ovarian cancer
    Eisenhauer, E. A.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 : 61 - 65
  • [5] The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance
    Fernandez, Lara P.
    Sanchez-Martinez, Ruth
    Vargas, Teodoro
    Herranz, Jesus
    Martin-Hernandez, Roberto
    Mendiola, Marta
    Hardisson, David
    Reglero, Guillermo
    Feliu, Jaime
    Redondo, Andres
    Ramirez de Molina, Ana
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [6] Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
    Gonzalez-Martin, A.
    Pothuri, B.
    Vergote, I.
    DePont Christensen, R.
    Graybill, W.
    Mirza, M. R.
    McCormick, C.
    Lorusso, D.
    Hoskins, P.
    Freyer, G.
    Baumann, K.
    Jardon, K.
    Redondo, A.
    Moore, R. G.
    Vulsteke, C.
    O'Cearbhaill, R. E.
    Lund, B.
    Backes, F.
    Barretina-Ginesta, P.
    Haggerty, A. F.
    Rubio-Perez, M. J.
    Shahin, M. S.
    Mangili, G.
    Bradley, W. H.
    Bruchim, I.
    Sun, K.
    Malinowska, I. A.
    Li, Y.
    Gupta, D.
    Monk, B. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (25) : 2391 - 2402
  • [7] NK Cells in the Tumor Microenvironment
    Guillerey, Camille
    [J]. TUMOR MICROENVIRONMENT: HEMATOPOIETIC CELLS, PT B, 2020, 1273 : 69 - 90
  • [8] GSVA: gene set variation analysis for microarray and RNA-Seq data
    Haenzelmann, Sonja
    Castelo, Robert
    Guinney, Justin
    [J]. BMC BIOINFORMATICS, 2013, 14
  • [9] Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques
    Haga, Yoshimi
    Ueda, Koji
    [J]. GLYCOCONJUGATE JOURNAL, 2022, 39 (02) : 303 - 313
  • [10] Vangl1 and Vangl2: planar cell polarity components with a developing role in cancer
    Hatakeyama, Jason
    Wald, Jessica H.
    Printsev, Ignat
    Ho, Hsin-Yi Henry
    Carraway, Kermit L., III
    [J]. ENDOCRINE-RELATED CANCER, 2014, 21 (05) : R345 - R356